Assignee
SWEDISH ORPHAN BIOVITRUM AG
CH·6 granted patents·2 pending applications·9 citations·filing 2016–2025
Top patents by PatentIndex Score
8 records- 0187US11034760B2Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkersSWEDISH ORPHAN BIOVITRUM AG·Filed 2016·Granted Jun 15, 2021·4 cites·17 claims
- 0286US11236158B2Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indicationsSWEDISH ORPHAN BIOVITRUM AG·Filed 2020·Granted Feb 1, 2022·2 cites·6 claims
- 0385US11091543B2Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indicationsSWEDISH ORPHAN BIOVITRUM AG·Filed 2017·Granted Aug 17, 2021·3 cites·9 claims
- 0482US2025101095A1Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indicationsSWEDISH ORPHAN BIOVITRUM AG·Filed 2024·Application pending·0 cites
- 0580US12297264B2Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indicationsSWEDISH ORPHAN BIOVITRUM AG·Filed 2023·Granted May 13, 2025·0 cites·10 claims
- 0674US12195530B2Methods, compositions and dosing regimens for treating or preventing interferon-gamma related indicationsSWEDISH ORPHAN BIOVITRUM AG·Filed 2021·Granted Jan 14, 2025·0 cites·17 claims
- 0763US12275785B2Methods and compositions for diagnosis and treatment of disorders in patients with elevated levels of CXCL9 and other biomarkersSWEDISH ORPHAN BIOVITRUM AG·Filed 2020·Granted Apr 15, 2025·0 cites·10 claims
- 0852US2025334587A1Use of emapalumab for treatmentSWEDISH ORPHAN BIOVITRUM AG·Filed 2025·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when SWEDISH ORPHAN BIOVITRUM AG files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →